ICON Early Phase Services  is looking for men and women ages 18-60, who are overweight or have obesity but otherwise healthy for a clinical research study.  This study is being done to test an investigational product for weight management. The study drug will be administered by subcutaneous injections (under the skin).

Click here to make an appointment for NO 0009-0431 MAD

Or call 210-225-5437 for more information

Vital signs, physical examinations,  ECGs, hormone level evaluation  and drug and alcohol screens will be performed.  Blood and urine samples will also be obtained during this study.

Participants will complete:

  • Up to 2 screening visits ( the first screening visit is non-fasting)
  •  22 overnights total
  •  8 outpatient visits

To determine if you fully qualify, it will be necessary to obtain blood samples after an 8-hour fast.  You have the option of fasting for the screening appointment, or, you may return at a later date.   For more information, see below.

Qualified participants may be compensated up to $11,500 for time and travel.


  Cohort 3A
1st Admit 6:00 AM May 10, 2021 Mon
Discharge May 14 Fri
2nd Admit 6:00 AM May 18, 2021 Tue
Discharge May 19 Wed
3rd Admit May 24, 2021 Mon
Discharge Jun 09 Wed
Day 31 Outpatient Visit Jun 10
Day 35 Outpatient Visit Jun 14
Day 42 Outpatient Visit Jun 21
Day 57 Outpatient Visit Jul 06
4th Admit 6:00 AM Jul 18, 2021 Sun
Discharge Jul 19
Day 84 Outpatient Visit Aug 02
Day 98 Aug 16
Day 112 Aug 30
Day 122 Sep 09
5th Admit 6:00 AM Sep 23, 2021 Thurs
Discharge Sep 24


If you are able to answer “YES” to the following statements, you may qualify for this study.

  •  I am a healthy adult who is overweight or has obesity and no significant medical conditions
  •  I am between 18 and 60 (inclusive) years old
  •  My BMI is between 27.0 and 39.9 kg/m2  inclusive
  •  I do not smoke or use any tobacco or nicotine products.  I agree not to smoke for the duration of the study and to abide by the rules of the clinic, which is a non-smoking facility.
  •  I have not participated in another clinical trial within 30 days before screening
  • If Female, I am not pregnant or breastfeeding
  • If Female, I am not capable of becoming pregnant.  I have been postmenopausal for at least 1 year or I am surgically sterile (tubes tied, uterus removed, tubes removed) or I was born sterile.
  •  If Male and I am sexually active with a partner capable of becoming pregnant, I have been sterilized (by vasectomy) or my partner must be willing to use a highly effective form of contraception.  Acceptable methods of contraception are:
    • Combined (estrogen and progestogen containing) hormonal contra- ception associated with inhibition of ovulation (oral, intravaginal, transdermal)
    • Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable)
    • Implantable progestogen-only hormonal contraception associated with inhibition of ovulation (intrauterine device (IUD), intrauterine hormone-releasing  system (IUS)
  • If Male, I do not plan to donate sperm in the period from screening until at least 4 weeks after the last follow-up visit

Screening Reminders -

  • 8 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment.
  • Bring a valid, non-expired photo ID with you when you attend your screening visit. We accept a government issued identification card such as a driver's license, state issued ID card, military ID or passport.  You will be required to show this same photo ID at all study visits.
  • Arrive 30 minutes before your appointment to complete paper work.